Product Code: ETC10515342 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The India congenital adrenal hyperplasia market import shipments demonstrated robust growth from 2020 to 2024, with a notable CAGR of 100.6%. The momentum continued into the last year with a growth rate of 42.5%, indicating a significant expansion trend in the market.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Congenital Adrenal Hyperplasia Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Congenital Adrenal Hyperplasia Market Revenues & Volume, 2021 & 2031F |
3.3 India Congenital Adrenal Hyperplasia Market - Industry Life Cycle |
3.4 India Congenital Adrenal Hyperplasia Market - Porter's Five Forces |
3.5 India Congenital Adrenal Hyperplasia Market Revenues & Volume Share, By Market Segment, 2021 & 2031F |
3.6 India Congenital Adrenal Hyperplasia Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.7 India Congenital Adrenal Hyperplasia Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.8 India Congenital Adrenal Hyperplasia Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 India Congenital Adrenal Hyperplasia Market Revenues & Volume Share, By Diagnosis Method, 2021 & 2031F |
4 India Congenital Adrenal Hyperplasia Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about congenital adrenal hyperplasia in India |
4.2.2 Rising prevalence of congenital adrenal hyperplasia cases |
4.2.3 Technological advancements in diagnosis and treatment of the condition |
4.3 Market Restraints |
4.3.1 Limited availability and accessibility of specialized healthcare services for congenital adrenal hyperplasia |
4.3.2 High cost associated with treatment and management of the condition |
4.3.3 Regulatory challenges in the approval and marketing of new therapies for congenital adrenal hyperplasia |
5 India Congenital Adrenal Hyperplasia Market Trends |
6 India Congenital Adrenal Hyperplasia Market, By Types |
6.1 India Congenital Adrenal Hyperplasia Market, By Market Segment |
6.1.1 Overview and Analysis |
6.1.2 India Congenital Adrenal Hyperplasia Market Revenues & Volume, By Market Segment, 2021 - 2031F |
6.1.3 India Congenital Adrenal Hyperplasia Market Revenues & Volume, By Corticosteroids, 2021 - 2031F |
6.1.4 India Congenital Adrenal Hyperplasia Market Revenues & Volume, By Mineralocorticoids, 2021 - 2031F |
6.1.5 India Congenital Adrenal Hyperplasia Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 India Congenital Adrenal Hyperplasia Market, By Drug Type |
6.2.1 Overview and Analysis |
6.2.2 India Congenital Adrenal Hyperplasia Market Revenues & Volume, By Oral Medications, 2021 - 2031F |
6.2.3 India Congenital Adrenal Hyperplasia Market Revenues & Volume, By Injections, 2021 - 2031F |
6.2.4 India Congenital Adrenal Hyperplasia Market Revenues & Volume, By Combination Therapies, 2021 - 2031F |
6.3 India Congenital Adrenal Hyperplasia Market, By Treatment Type |
6.3.1 Overview and Analysis |
6.3.2 India Congenital Adrenal Hyperplasia Market Revenues & Volume, By Hormone Replacement, 2021 - 2031F |
6.3.3 India Congenital Adrenal Hyperplasia Market Revenues & Volume, By Surgical Treatment, 2021 - 2031F |
6.3.4 India Congenital Adrenal Hyperplasia Market Revenues & Volume, By Adrenalectomy, 2021 - 2031F |
6.4 India Congenital Adrenal Hyperplasia Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 India Congenital Adrenal Hyperplasia Market Revenues & Volume, By Patients, 2021 - 2031F |
6.4.3 India Congenital Adrenal Hyperplasia Market Revenues & Volume, By Endocrinologists, 2021 - 2031F |
6.4.4 India Congenital Adrenal Hyperplasia Market Revenues & Volume, By Pediatric Endocrinologists, 2021 - 2031F |
6.5 India Congenital Adrenal Hyperplasia Market, By Diagnosis Method |
6.5.1 Overview and Analysis |
6.5.2 India Congenital Adrenal Hyperplasia Market Revenues & Volume, By Blood Tests, 2021 - 2031F |
6.5.3 India Congenital Adrenal Hyperplasia Market Revenues & Volume, By Genetic Testing, 2021 - 2031F |
6.5.4 India Congenital Adrenal Hyperplasia Market Revenues & Volume, By Imaging Tests, 2021 - 2031F |
7 India Congenital Adrenal Hyperplasia Market Import-Export Trade Statistics |
7.1 India Congenital Adrenal Hyperplasia Market Export to Major Countries |
7.2 India Congenital Adrenal Hyperplasia Market Imports from Major Countries |
8 India Congenital Adrenal Hyperplasia Market Key Performance Indicators |
8.1 Average time taken for diagnosis of congenital adrenal hyperplasia |
8.2 Number of healthcare professionals trained in managing congenital adrenal hyperplasia |
8.3 Patient adherence to treatment plans |
8.4 Number of research studies and clinical trials conducted on congenital adrenal hyperplasia |
8.5 Availability of support groups for patients and families affected by congenital adrenal hyperplasia |
9 India Congenital Adrenal Hyperplasia Market - Opportunity Assessment |
9.1 India Congenital Adrenal Hyperplasia Market Opportunity Assessment, By Market Segment, 2021 & 2031F |
9.2 India Congenital Adrenal Hyperplasia Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.3 India Congenital Adrenal Hyperplasia Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.4 India Congenital Adrenal Hyperplasia Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 India Congenital Adrenal Hyperplasia Market Opportunity Assessment, By Diagnosis Method, 2021 & 2031F |
10 India Congenital Adrenal Hyperplasia Market - Competitive Landscape |
10.1 India Congenital Adrenal Hyperplasia Market Revenue Share, By Companies, 2024 |
10.2 India Congenital Adrenal Hyperplasia Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |